Brand-name drug
Relexxii price, strengths & recalls
Brand of methylphenidate (generic)
Pharmacies pay $328.34 for 30 tablets of Relexxii 18 mg (24 hr) extended-release tablet this week, and from $328.34 to $655.56 across its 6 priced strengths and forms. The generic, methylphenidate, costs pharmacies from $3.65. It is in shortage (unavailable). It has 24 recalls on record, none ongoing. Its official label last changed on September 29, 2025.
UnavailableBrand- Fair cash price
- $388.09
- Strengths
- 6
- Makers
- 1
- Updated
- Nov 11
Relexxii price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 18 mg (24 hr) extended-release tablet Brand | $10.94 | $328.34 / 30 tablets |
| 27 mg (24 hr) extended-release tablet Brand | $11.39 | $341.56 / 30 tablets |
| 36 mg (24 hr) extended-release tablet Brand | $11.87 | $356.06 / 30 tablets |
| 54 mg (24 hr) extended-release tablet Brand | $12.78 | $383.34 / 30 tablets |
| 63 mg (24 hr) extended-release tablet Brand | $21.34 | $640.18 / 30 tablets |
| 72 mg (24 hr) extended-release tablet Brand | $21.85 | $655.56 / 30 tablets |
The lowest cost per tablet is 18 mg (24 hr) extended-release tablet at $10.94. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Relexxii vs generic methylphenidate
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 18 mg (24 hr) extended-release tablet | $328.34 | $18.29 | 18x |
| 27 mg (24 hr) extended-release tablet | $341.56 | $21.56 | 15.8x |
| 36 mg (24 hr) extended-release tablet | $356.06 | $20.68 | 17.2x |
| 54 mg (24 hr) extended-release tablet | $383.34 | $24.66 | 15.5x |
| 63 mg (24 hr) extended-release tablet | $640.18 | $570.00 | 1.1x |
| 72 mg (24 hr) extended-release tablet | $655.56 | $482.67 | 1.4x |
Supply status: shortages & recalls
Shortages
- Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
- Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)Temporary discontinuation of 100ct
- Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)Temporary discontinuation of 100ct
- Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)Allocation to current contracted customers
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)Allocation to current contracted customers
- Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 24 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Relexxii
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use RELEXXII® safely and effectively. See full prescribing information for RELEXXII®.RELEXXII® (methylphenidate hydrochloride extended-release tablets) for oral use, CIIInitial U.S. Approval: 2000
WARNING: ABUSE, MISUSE, AND ADDICTION
RELEXXII has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including RELEXXII, can result in overdose and death [see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Before prescribing RELEXXII, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout RELEXXII treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions (5.1) and Drug Abuse and Dependence (9.2)].
WARNING: ABUSE, MISUSE, AND ADDICTION
See full prescribing information for complete boxed warning.
RELEXXII has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including RELEXXII, can result in overdose and death (5.1, 9.2, 10):
Before prescribing RELEXXII, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.
Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES
Indications and Usage (1) 09/2025
Warnings and Precautions (5.7) 09/2025
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA216117 · Osmotica Pharm US
- First approved
- June 23, 2022 (4 years ago)
- Latest approved change
- September 23, 2025
- Approved label
- PDF, Sep 25, 2025
- Generic makers
- 31 approved generic applications on the market
- Last patent listed
- February 3, 2037
Relexxii questions
How much does relexxii cost without insurance?
Pharmacies pay about $328.34 for 30 tablets of relexxii 18 mg (24 hr) extended-release tablet ($10.94 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $388.09. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Relexxii?
Yes: methylphenidate. Pharmacies pay from $3.65 for it. Compare methylphenidate prices.
Is relexxii in shortage?
Yes. 38 products are listed as in shortage or being discontinued (unavailable). See which ones.
Has relexxii been recalled?
24 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the relexxii label last change?
The official label was last updated on September 29, 2025 (version 18). See what changed.
Talk about relexxii
No comments yet. Questions, tips, what worked for you - start the conversation.